3WV-22774-59491
3 vaccinations
1 coded response
10 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 208 / MD
- Registered
- 2021-12-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-29
Dose 2 — Pfizer-BioNTech
-
2021-12-27
Registered in v-safe
-
2021-12-27
Dose 3 — Pfizer-BioNTech
- 2021-12-27
- 2021-12-28
- 2021-12-29
- 2021-12-30
- 2022-01-05
- 2022-01-17
-
2022-02-02
Survey response — day 35, dose 3MedDRA: Foetal growth restriction, Oligohydramnios — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Low amniotic fluid & IUGR babyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-02
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-07
- 2022-02-22
- 2022-03-30
- 2022-06-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | No |
| 2 | 2021-03-29 | Pfizer-BioNTech | No |
| 3 | 2021-12-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-02 | Unsuccessful |
Free text
Release 11 — day 35, dose 3
Symptoms: Low amniotic fluid & IUGR baby
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Foetal growth restriction | · | · | ✓ |
| SD | Oligohydramnios | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release